An underground economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Investigational Treatment Acquiring Popularity Via Social Media
Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Followers are encouraged to message these profiles privately for source information, while also obtaining promotional offers.
Active Trade on Social Networks
Separately, a flourishing trade exists on Telegram, where groups with numerous of members share “before and after” photos, administration instructions and assertions of next-day UK delivery. Sellers market the substance there before directing customers to other platforms for transactions.
Learning About The Experimental Drug
This medication is an experimental injection created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could assist individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Medical Experts Voice Concerns
Nevertheless, doctors and pharmacists have warned that the sale of what is still an unlicensed medication in the UK is a cause for concern and could result in users administering substances of unknown origin.
Several professionals stated the demand for the experimental drug could be linked to the increasing cost of approved weight loss treatments such as Mounjaro.
Legal Position and Enforcement
Marketing the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be promoted or supplied for personal consumption under the British medical regulations.
Some content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still violate pharmaceutical, advertising, and consumer laws, risking penalties, prosecution or prison.
Platform Reaction and Material Elimination
According to the social media company, the platform has removed violative material and prohibited related keywords and search suggestions. The organization said it was committed to maintaining the service secure and allocating resources in enhancing compliance measures.
Digital Marketplace Operations
Investigations also discovered groups with up to 9,000 members marketing retatrutide using Telegram's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays channels with thousands of members, populated with images of weight loss, positive reviews and step-by-step instructions for mixing or injecting at home.
After minutes of joining one community, a seller posted WhatsApp details, where most transactions take place. The vendor provided an instruction manual and promised shipping within 48 hours. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None inquired about body mass, medical conditions or past usage.
Item Information and Pricing
Within these groups, posts display dark colored parcels with postal service stickers, stating to include new batches. One message stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at residence with sterile water, or pre-filled pens usually sold at 160 pounds for 20mg. When questioned how much time a injector should last, vendors give conflicting answers varying between a few weeks to “depends on your body”.
Service Oversight and Security Measures
A representative for Telegram said it regularly monitored harmful material on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are injecting materials they cannot confirm. Although the research behind retatrutide is sound, these online products may not contain what they claim,” said Jason Murphy, the head of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor connected the surge in interest to current cost increases for approved weight-loss medications such as Mounjaro. “With prices increasing, patients are using social media. But fake treatments are extremely dangerous. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.
Her team has previously encountered patients injured by personal administration from unverified suppliers. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your health,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”
Producer Position
A spokesperson from Eli Lilly said the substance was in third stage clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a company investigational product not yet authorized … may expose users to potentially significant medical dangers”.
